Literature DB >> 1740409

The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism.

T F Zioncheck1, S Roy, G A Vehar.   

Abstract

Tissue factor (TF) is an integral membrane glycoprotein that serves as a cellular receptor and cofactor for the activation of the plasma protease factor VII. TF activity in both monocytes and endothelial cells is regulated by various cytokines and mitogens, including the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA). Three TF constructs (full-length human, a cytoplasmic domain deletion mutant, and a human-rat TF chimera), expressed in a human kidney cell line, were used to examine the in vivo phosphorylation state of TF after PMA treatment. The cytoplasmic domains of both rat and human TF were rapidly phosphorylated after cells were treated with 10-100 nM PMA. This response was completely abolished by preincubating cells with staurosporine, the potent PKC inhibitor, prior to PMA treatment. Localization of the phosphorylation site(s) to the cytoplasmic domain was demonstrated using a deletion mutant of TF and by CNBr digestion at the single methionine residue (Met-210) in the TF sequence. The rat TF cytoplasmic domain was phosphorylated to a higher specific activity than the human TF cytoplasmic domain. Phosphoamino acid analysis of the chimeric TF revealed both phosphothreonine and phosphoserine, whereas human TF contained only phosphoserine. Thus both potential phosphoacceptor sites are phosphorylated in the rat TF cytoplasmic domain. Alignment of TF cDNA sequences of mouse, rat, rabbit, and man revealed that the phosphoacceptor site (X-S*/T*-P-X, where asterisk indicates the phosphorylated residue) in the cytoplasmic domain has been conserved through evolution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740409

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.

Authors:  Christoph Reinhardt; Mattias Bergentall; Thomas U Greiner; Florence Schaffner; Gunnel Ostergren-Lundén; Lars C Petersen; Wolfram Ruf; Fredrik Bäckhed
Journal:  Nature       Date:  2012-03-11       Impact factor: 49.962

Review 2.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

3.  Hinge bending within the cytokine receptor superfamily revealed by the 2.4 A crystal structure of the extracellular domain of rabbit tissue factor.

Authors:  Y A Muller; R F Kelley; A M de Vos
Journal:  Protein Sci       Date:  1998-05       Impact factor: 6.725

4.  Effect of tissue factor deficiency on mouse and tumor development.

Authors:  J R Toomey; K E Kratzer; N M Lasky; G J Broze
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 5.  The hemostatic system and angiogenesis in malignancy.

Authors:  M Z Wojtukiewicz; E Sierko; P Klement; J Rak
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

6.  Porcine amelogenins.

Authors:  Y Yamakoshi; T Tanabe; M Fukae; M Shimizu
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

Review 7.  The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer.

Authors:  F R Rickles; M Shoji; K Abe
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

8.  Tissue factor as a novel target for treatment of breast cancer.

Authors:  Marion Cole; Michael Bromberg
Journal:  Oncologist       Date:  2013-01-03

Review 9.  Targeting clotting proteins in cancer therapy - progress and challenges.

Authors:  Wolfram Ruf; Andrea S Rothmeier; Claudine Graf
Journal:  Thromb Res       Date:  2016-04       Impact factor: 3.944

Review 10.  Regulation of tissue factor coagulant activity on cell surfaces.

Authors:  L V M Rao; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.